Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
Open Access
- 31 December 2006
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 45 (6) , 786-796
- https://doi.org/10.1016/j.jhep.2006.07.030
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor-γ and Retinoic Acid X Receptor α Represses theTGFβ1Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 DephosphorylationMolecular Pharmacology, 2006
- Involvement of the serine/threonine p70S6 kinase in TGF-β1-induced ADAM12 expression in cultured human hepatic stellate cellsJournal of Hepatology, 2005
- The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell ProliferationJournal of Biological Chemistry, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- Mammalian Target of Rapamycin Positively Regulates Collagen Type I Production via a Phosphatidylinositol 3-Kinase-independent PathwayJournal of Biological Chemistry, 2004
- Neutrophils Aggravate Acute Liver Injury During Obstructive Cholestasis in Bile Duct-Ligated MiceHepatology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administrationDigestive Diseases and Sciences, 1993
- The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: Correlation with morphometric measurement of hepatocyte massHepatology, 1987
- Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosisJournal of Hepatology, 1986